Global Anti-Cancer Drug Market Growth 2023-2029

Global Anti-Cancer Drug Market Growth 2023-2029

Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.

LPI (LP Information)' newest research report, the “Anti-Cancer Drug Industry Forecast” looks at past sales and reviews total world Anti-Cancer Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Cancer Drug sales for 2023 through 2029. With Anti-Cancer Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Cancer Drug industry.

This Insight Report provides a comprehensive analysis of the global Anti-Cancer Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Cancer Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-Cancer Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Cancer Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Cancer Drug.

The global Anti-Cancer Drug market size is projected to grow from US$ 82440 million in 2022 to US$ 107200 million in 2029; it is expected to grow at a CAGR of 107200 from 2023 to 2029.

China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.

Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Cancer Drug market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Avastin
Rituxan
Herceptin
Alimta

Segmentation by application
Hospital
Clinic
Home Care

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Bristol-Myers Squibb
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche Ltd.
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-Cancer Drug market?

What factors are driving Anti-Cancer Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-Cancer Drug market opportunities vary by end market size?

How does Anti-Cancer Drug break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.